Reach Us +44-1235425476
Critical Normal Structures Doses for Non Small Cell Lung Cancer using 3-D Conformal Radiotherapy | OMICS International | Abstract
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Critical Normal Structures Doses for Non Small Cell Lung Cancer using 3-D Conformal Radiotherapy

Karacetin Didem1*, Cakir Aydin3, Karaman Sule2, Kemikler Ebru2, Tenekeci Nuri4, Saglam K Esra2, Oral Ethem Nezih2 and Kizir Ahmet2

1Sisli Etfal Research and Training Hospital, Radiation Oncology Clinic, Istanbul, Turkey

2I.U. I.M.F. Radiation Oncology Clinic, Istanbul, Turkey

3I.U. I.M.F. Radiation Physic Department, Istanbul, Turkey

4I.U. Institute of Oncology, Radiology Department, Istanbul, Turkey

*Corresponding Author:
Karacetin Didem
Sisli Etfal Research and Training Hospital
Radiation Oncology Clinic
Istanbul, Turkey
E-mail: [email protected]

Received date: March 14, 2012; Accepted date: April 11, 2012; Published date: April 14, 2012

Citation: Didem K, Aydin C, Sule K, Ebru K, Nuri T, et al. (2012) Critical Normal Structures Doses for Non Small Cell Lung Cancer using 3-D Conformal Radiotherapy. J Nucl Med Radiat Ther 3:128. doi:10.4172/2155-9619.1000128

Copyright: © 2012 Didem K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Purpose: In this prospective study, we have aimed to analyze the levels of doses and toxicities of critical normal structures in the treatment of non-small cell lung cancer (NSCLC) with 3-D Conformal Radiotherapy.

Material and Method: We have evaluated 24 patients with biopsy proven inoperable NSCLC stages III, treated with Conformal Radiotherapy. After CT- simulation, GTV, CTV, PTV and critical normal structures (lungs, esophagus, heart, and spinal cord) were contoured by the physician and radiologist and then dose volumes were calculated. Chemoradiotherapy was used in these patients after induction treatment. Induction chemotherapy was administrated: Docetaxe l75 mg/m² + Cisplatin 75 mg/m² from day 1 for each 21 days, total 3 cycles. After induction therapy concomitant Docetaxel 25 mg/m² + Cisplatin 25 mg/m² were administrated weekly for 5 to 6 weeks and radiotherapy was delivered with linear accelerator, 64 – 66 Gy/32 – 33 fr/200 cGy/d. The study endpoints were critical normal structures doses, early and late toxicities, and local control.

Results: DVH: Lungs V20 is 32%. Heart Dmean doses are 1892 cGy (Dmin 22 cGy - Dmax. 4084 cGy). Esophagus Dmean doses are 2700 cGy (Dmin. 912 cGy - Dmax. 4513 cGy) and Spinal cord Dmean is 1201 cGy (Dmin. 115 cGy - Dmax. 2139 cGy). Acute toxicities; 18 patients (75%) have grade I-II esophagitis, 6 patients (25%) have grade III esohagitis, 7 patients (29%) have grade III-IV pneumonia and 4 patients (16,6 %) have grade I-II pneumonia. No late toxicity has been observed in esophagus, heart and even lungs. Median follow-up was 13 months and local control rate was 41.6%.

Conclusion: This study confirms that 3-D Conformal Radiotherapy is an effective treatment with NSCLC. But patients in the study have large tumors or tumors near critical locations, so critical normal structures doses were high compared with literature.


Recommended Conferences

Clinical Oncology & Radiation Therapy

Singapore, Singapore
Share This Page